Pablo Vidal
Impact in
-
- Antibiotic Use and Resistance
-
- Nosocomial Infections in ICU
Papers in ⓘ
-
- Nosocomial Infections in ICU 10
- Co-authors
- T. Deckert (3 shared papers)Bo Feldt‐Rasmussen (2 shared papers)Allan Kofoed‐Enevoldsen (1 shared paper)K. N�rgaard (1 shared paper)Paula Ramírez (6 shared papers)Ignacio Martín‐Loeches (6 shared papers)Emili Dı́az (7 shared papers)Ricard Ferrer (3 shared papers)
In The Last Decade
Pablo Vidal
49 papers receiving 606 citations
Peers
Comparison fields: 5 of 115
- Applied Microbiology and Biotechnology 58
- Critical Care and Intensive Care Medicine 104
- Clinical Biochemistry 103
- Nephrology 107
- Molecular Medicine 59
Countries citing papers authored by Pablo Vidal
This map shows the geographic impact of Pablo Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Vidal more than expected).
Fields of papers citing papers by Pablo Vidal
This network shows the impact of papers produced by Pablo Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Vidal. The network helps show where Pablo Vidal may publish in the future.
Co-authors
The 25 scholars most cited alongside Pablo Vidal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 109 | |
| 2 | 1993 | 104 | |
| 3 | 1986 | 60 | |
| 4 | Current aspects in sepsis approach. Turning things around. | 2018 | 41 |
| 5 | 2014 | 27 | |
| 6 | 1993 | 20 | |
| 7 | 2022 | 18 | |
| 8 | 2014 | 16 | |
| 9 | 2020 | 15 | |
| 10 | 2020 | 13 | |
| 11 | 2014 | 13 | |
| 12 | 2018 | 13 | |
| 13 | 2021 | 12 | |
| 14 | 2020 | 12 | |
| 15 | 1989 | 12 | |
| 16 | 2019 | 11 | |
| 17 | 2022 | 11 | |
| 18 | 1992 | 10 | |
| 19 | 2021 | 9 | |
| 20 | 2021 | 8 |
About Pablo Vidal
Pablo Vidal is a scholar working on Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology, Clinical Biochemistry, Molecular Medicine and Family Practice, having authored 55 papers that have together received 622 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (12 papers), Nosocomial Infections in ICU (10 papers), Advanced Glycation End Products research (10 papers), Connexins and lens biology (7 papers), Biochemical effects in animals (6 papers), COVID-19 Clinical Research Studies (6 papers), Antibiotic Resistance in Bacteria (5 papers) and Long-Term Effects of COVID-19 (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (58 citations), Critical Care and Intensive Care Medicine (104 citations), Clinical Biochemistry (103 citations), Nephrology (107 citations) and Molecular Medicine (59 citations). Pablo Vidal has collaborated with scholars based in Spain, Denmark and Chile. Frequent co-authors include T. Deckert, Bo Feldt‐Rasmussen, Allan Kofoed‐Enevoldsen, K. N�rgaard, Paula Ramírez, Ignacio Martín‐Loeches, Emili Dı́az, Ricard Ferrer, Emilio Maseda and Alejandro Rodríguez. Their work appears in journals such as Critical Care, Antibiotics, Acta Ophthalmologica, Diabetologia and Ophthalmic Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.